medicine is It’s trying to achieve the long-held goal of the “morning-after pill” to prevent sexually transmitted infections. It has the potential to significantly reduce burgeoning disease incidence and enormous health care costs.
The efficacy of this pill is literally a 200 milligram pill of the antibiotic doxycycline and has been studied for 10 years.However, research results have been published New England Journal of Medicine It seems likely that the pill will be applied in clinical practice. The study, conducted in San Francisco and Seattle, found that participants who took one dose within 72 hours of having condomless sex were more likely to contract chlamydia, gonorrhea, or syphilis than those who did not. but only he was a third.
As with all of medicine, the findings have footnotes and risks to balance benefits. Conducted for binary people only. Among these groups, it was restricted to those diagnosed with a sexually transmitted infection (STI) in the past year. Cisgender women were not included in this study. In previous studies, prophylactic antibiotics did not do much for them. It was noted that resistance could be caused among any of the other bacteria that have been tested, but were not investigated in detail.
That said, the results have caused real excitement among doctors and people eligible to take something called doxycycline for post-exposure prophylaxis. No formal recommendations for its use have yet been made.
“I think it’s a real game changer,” says Paul Adamson, an infectious disease physician and clinical assistant professor of medicine at the University of California, Los Angeles. “There is an enormous amount of bacterial STIs in the United States. Gay and bisexual men who have sex with men are disproportionately burdened. “
To understand why doxyPEP is so important, it’s important to consider what’s going on with STDs. Simply put, they are skyrocketing. The most important of these diseases have reached historic highs since 2017, with gonorrhea up 28% and syphilis up 74%, according to the CDC. And while chlamydia diagnoses have not fully returned to pre-Covid levels, officials are concerned this may be due to treatment disruptions due to the pandemic rather than an actual decline in transmission. All of these infections have serious long-term consequences, including making people more susceptible to HIV infection if not diagnosed and treated. In total, they cost the U.S. healthcare system over $1 billion annually.
On the other hand, congenital syphilis, which is transmitted from mother to infant at birth, is a sign that pregnant women are not receiving adequate prenatal care, causing 220 stillbirths and infant deaths in 2021. Gonorrhea has acquired resistance to the last antibiotic currently available to treat it.
